News
02-11-2009, 02:52 AM
New Jersey's only NCI-designated Comprehensive Cancer Center is taking part in a worldwide clinical trial targeting HER2 positive breast cancer, which accounts for up to 25 percent of all breast cancers.
More... (http://www.news-medical.net/?id=45775)
More... (http://www.news-medical.net/?id=45775)